Charles River Laboratories International Aktie
117,29USD | 2,21USD | 1,92% |
WKN: 939391 / ISIN: US1598641074
Personal
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 18 400 | 20 000 | 21 400 | 21 800 | 20 100 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,16 | 0,18 | 0,19 | 0,19 | 0,20 |
Bilanz (in Mio. EUR) - Aktiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 1 201 | 1 274 | 1 439 | 1 609 | 1 403 |
Summe Anlagevermögen | 4 275 | 5 487 | 6 124 | 6 724 | 6 243 |
Summe Aktiva | 5 491 | 7 024 | 7 603 | 8 195 | 7 528 |
Bilanz (in Mio. EUR) - Passiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 2 160 | 2 953 | 3 147 | 3 127 | 2 781 |
Summe Fremdkapital | 3 347 | 4 432 | 4 579 | 4 536 | 4 020 |
Summe Eigenkapital | 2 144 | 2 592 | 3 024 | 3 659 | 3 508 |
Summe Passiva | 5 491 | 7 024 | 7 603 | 8 195 | 7 528 |
Adresse
251 Ballardvale Street, 01887 Wilmington | |
Telefon | +1 (781) 222-6000 |
Internet | http://www.criver.com |
Management
Birgit Girshick
Chief Operating Officer & Executive Vice President |
Brian Bathgate
Senior Vice President-European Safety Assessment |
Colin Dunn
Senior VP, GM-Research Models & Services |
Craig B. Thompson
Independent Director |
Deborah Turner Kochevar
Independent Director |
Flavia H. Pease
Chief Financial Officer & Executive Vice President |
Foster T. Jordan
Senior Vice President-Microbial Solutions |
George E. Massaro
Lead Independent Director |
George Llado
Independent Director |
Gina M. Mullane
Chief Marketing Officer & Senior Vice President |
James C. Foster
Chairman, President & Chief Executive Officer |
John C. Ho
Chief Strategy Officer & SVP-Corporate Strategy |
Joseph W. LaPlume
Executive VP-Corporate Development & Strategy |
Julie Frearson
Chief Scientific Officer & Senior Vice President |
Kristen M. Eisenhauer
Chief Commercial Officer & Senior Vice President |
Mark Mintz
Chief Information Officer & Senior Vice President |
Martin W. MacKay
Independent Director |
Matthew L. Daniel
Secretary, Chief Compliance Officer & Senior VP |
Michael Gunnar Knell
Chief Accounting Officer & Senior Vice President |
Nancy C. Andrews
Independent Director |
Reshema Kemps-Polanco
Independent Director |
Richard F. Wallman
Independent Director |
Robert J. Bertolini
Independent Director |
Shannon M. Parisotto
Executive VP-Global Discovery & Safety Assessment |
Todd Spencer
Vice President-Investor Relations |
Victoria L. Creamer
Chief People Officer & Executive Vice President |
Virginia M. Wilson
Independent Director |